Jie Lin, Binbin Xue, Dewei Xie, Jia Li, Juyuan Pan, Lanbing Zhu et al. Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD. // Annals of Clinical and Translational Neurology. – 2026. – DOI: 10.1002/acn3.70412. – URL: https://onlinelibrary.wiley.com/doi/10.1002/acn3.70412?af=R
Jie Lin, Binbin Xue, Dewei Xie, Jia Li, Juyuan Pan, Lanbing Zhu, Qiaowen Tong, Jing Lin, Ruofan Zhu, Xu Zhang, Junhui Xia, & Xiang Li (2026). Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.70412
Jie Lin, et al. “Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD.” Annals of Clinical and Translational Neurology, 2026. doi:10.1002/acn3.70412.
@article{Lin2026,
title = {Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD},
author = {Lin, Jie and Xue, Binbin and Xie, Dewei and Li, Jia and Pan, Juyuan and Zhu, Lanbing and Tong, Qiaowen and Lin, Jing and Zhu, Ruofan and Zhang, Xu and Xia, Junhui and Li, Xiang},
journal = {Annals of Clinical and Translational Neurology},
year = {2026},
doi = {10.1002/acn3.70412},
url = {https://onlinelibrary.wiley.com/doi/10.1002/acn3.70412?af=R}
}